329 related articles for article (PubMed ID: 30882490)
21. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
[TBL] [Abstract][Full Text] [Related]
22. Food insecurity and HIV clinical outcomes in a longitudinal study of urban homeless and marginally housed HIV-infected individuals.
Weiser SD; Yuan C; Guzman D; Frongillo EA; Riley ED; Bangsberg DR; Kushel MB
AIDS; 2013 Nov; 27(18):2953-8. PubMed ID: 23921612
[TBL] [Abstract][Full Text] [Related]
23. Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.
Childs T; Shingadia D; Goodall R; Doerholt K; Lyall H; Duong T; Judd A; Gibb DM; Collins IJ;
Lancet HIV; 2015 Apr; 2(4):e151-8. PubMed ID: 26413561
[TBL] [Abstract][Full Text] [Related]
24. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation.
Girometti N; Nwokolo N; McOwan A; Whitlock G
Antivir Ther; 2017; 22(1):77-80. PubMed ID: 27585954
[TBL] [Abstract][Full Text] [Related]
26. Disparities and Trends in Viral Suppression During a Transition to a "Test and Treat" Approach to the HIV Epidemic, San Francisco, 2008-2012.
Schwarcz S; Hsu LC; Scheer S
J Acquir Immune Defic Syndr; 2015 Dec; 70(5):529-37. PubMed ID: 26569177
[TBL] [Abstract][Full Text] [Related]
27. Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.
Mendez-Lopez A; McKee M; Stuckler D; Granich R; Gupta S; Noori T; Semenza JC
HIV Med; 2019 Sep; 20(8):501-512. PubMed ID: 31140715
[TBL] [Abstract][Full Text] [Related]
28. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
Fatti G; Mothibi E; Shaikh N; Grimwood A
AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
[TBL] [Abstract][Full Text] [Related]
30. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
Haghighat R; Toska E; Bungane N; Cluver L
BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
32. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
Imbert E; Hickey MD; Clemenzi-Allen A; Lynch E; Friend J; Kelley J; Conte M; Das D; Rosario JBD; Collins E; Oskarsson J; Hicks ML; Riley ED; Havlir DV; Gandhi M
AIDS; 2021 Jul; 35(8):1241-1246. PubMed ID: 34076613
[TBL] [Abstract][Full Text] [Related]
34. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
Lesko CR; Tong W; Moore RD; Lau B
AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.
Wood SM; Lowenthal E; Lee S; Ratcliffe SJ; Dowshen N
AIDS Patient Care STDS; 2017 Sep; 31(9):377-383. PubMed ID: 28891717
[TBL] [Abstract][Full Text] [Related]
36. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
[TBL] [Abstract][Full Text] [Related]
37. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis.
Hoenigl M; Chaillon A; Moore DJ; Morris SR; Mehta SR; Gianella S; Amico KR; Little SJ
Sci Rep; 2016 Sep; 6():32947. PubMed ID: 27597312
[TBL] [Abstract][Full Text] [Related]
38. Viral suppression and viral rebound among young adults living with HIV in Canada.
Palmer A; Gabler K; Rachlis B; Ding E; Chia J; Bacani N; Bayoumi AM; Closson K; Klein M; Cooper C; Burchell A; Walmsley S; Kaida A; Hogg R;
Medicine (Baltimore); 2018 Jun; 97(22):e10562. PubMed ID: 29851775
[TBL] [Abstract][Full Text] [Related]
39. Rapid Antiretroviral Therapy Program: Development and Evaluation at a Veterans Affairs Medical Center in the Southern United States.
O'Shea JG; Gallini JW; Cui X; Moanna A; Marconi VC
AIDS Patient Care STDS; 2022 Jun; 36(6):219-225. PubMed ID: 35587641
[TBL] [Abstract][Full Text] [Related]
40. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
